Company Filing History:
Years Active: 2013
Title: Yeun-Jin Ju: Innovator in Cancer Treatment
Introduction
Yeun-Jin Ju is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the development of innovative treatments for malignant tumors. His work focuses on utilizing genetic components to enhance cancer therapies.
Latest Patents
Yeun-Jin Ju holds a patent for a pharmaceutical composition aimed at treating malignant tumors. This composition includes a human p31 gene encoding protein, which has been shown to suppress cancer cell growth, induce apoptosis, and effectively kill cells by overexpressing p31 in solid malignant tumor cells. This innovative approach offers promising potential for gene therapy applications in oncology.
Career Highlights
Ju is affiliated with the Korea Institute of Radiological and Medical Sciences, where he conducts research and develops new therapeutic strategies. His work is characterized by a commitment to advancing cancer treatment methodologies through scientific innovation.
Collaborations
Some of his notable coworkers include Kee-Ho Lee and Sang-Hoon Kim, who collaborate with him on various research projects aimed at improving cancer therapies.
Conclusion
Yeun-Jin Ju's contributions to cancer treatment through his innovative patent highlight the importance of genetic research in developing effective therapies. His work continues to inspire advancements in the medical field.